Status:
COMPLETED
REmote MOnitoring Transmission Evaluation of IPGs
Lead Sponsor:
Medtronic Cardiac Rhythm and Heart Failure
Conditions:
Pacemaker
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the potential clinical and economic benefits of using CareLink remote management for pacemaker follow-up. Study Objectives include: 1. To determine clinician...
Eligibility Criteria
Inclusion
- Patients who have received a market released Medtronic pacemaker with automatic threshold management features for all active leads.
- Patients who have been implanted with their current pacemaker for at least 3 months.
- Patients who are willing, or who have caregivers willing, to use the Medtronic CareLink Monitor.
- Patients who are willing and able to sign an IRB/MEC approved patient informed consent.
Exclusion
- Patients participating in another study that would affect the objectives of this study
- Patients who have already previously used a Medtronic CareLink Monitor.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00631709
Start Date
March 1 2008
End Date
February 1 2010
Last Update
April 26 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Kelowna General Hospital
Kelowna, British Columbia, Canada
2
Southlake Regional Hospital
Newmarket, Ontario, Canada
3
CHUQ, L'Hotel Dieu de Quebec
Québec, Quebec, Canada